SMTL ID : 3orn.1 (1 other biounit)

Mitogen-activated protein kinase kinase 1 (MEK1) in complex with CH4987655 and MgAMP-PNP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 23 residues within 4Å: Chain A: L.14, G.15, A.16, G.17, N.18, G.19, G.20, V.22, A.35, K.37, M.83, E.84, H.85, M.86, S.90, Q.93, K.132, S.134, N.135, L.137, D.148 Ligands: MG.2, 3OR.3 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:G.17, A:N.18, A:N.18, A:G.19, A:E.84, A:H.85, A:M.86, A:S.90, A:S.90, A:K.132, A:S.134 Water bridges: A:A.16, A:Q.93 Salt bridges: A:K.37

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 5 residues within 4Å: Chain A: K.37, S.134, N.135, D.148 Ligands: ANP.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.148

1 x 3OR: 3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-5-[(3-oxo-1,2-oxazinan-2-yl)methyl]benzamide(Non-covalent)

3OR.3: 22 residues within 4Å: Chain A: G.19, G.20, K.37, I.39, L.55, L.58, V.67, I.81, M.83, H.128, R.129, D.130, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159, N.161 Ligands: ANP.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.58, A:I.81, A:R.129, A:L.155, A:N.161 Hydrogen bonds: A:K.37, A:D.148 pi-Stacking: A:F.149 Halogen bonds: A:V.67, A:S.152

1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)

PGE.4: 6 residues within 4Å: Chain A: I.126, R.129, G.150, V.151, G.153, I.156 1 PLIP interactions: 1 interactions with chain A Water bridges: A:M.127

6 x SO4: SULFATE ION(Non-functional Binders)

SO4.5: 4 residues within 4Å: Chain A: N.18, G.165, T.166, R.167 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.18, A:T.166, A:R.167, A:R.167 Water bridges: A:T.166 Salt bridges: A:R.167 SO4.6: 3 residues within 4Å: Chain A: H.40, L.41, E.42 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.42 SO4.7: 3 residues within 4Å: Chain A: R.121, S.181, V.182 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:V.182 Water bridges: A:R.121 Salt bridges: A:R.121 SO4.8: 6 residues within 4Å: Chain A: R.141, G.142, V.277, D.278, F.279, A.280 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:F.279, A:A.280 Water bridges: A:G.142 SO4.9: 4 residues within 4Å: Chain A: S.239, L.240, E.241, R.271 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.240, A:E.241 Salt bridges: A:R.271 SO4.10: 2 residues within 4Å: Chain A: E.9, K.10 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.10 Salt bridges: A:K.10

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Isshiki, Y. et al., Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-03-02

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence